Clinical Trials Logo

Filter by:
NCT ID: NCT00139048 Completed - Clinical trials for Knowledge of Mammography Screening

Australian Screening Mammography Decision Aid Trial: A Decision Aid for Women Aged 40 Thinking About Starting Mammography Screening

Start date: September 2005
Phase: N/A
Study type: Interventional

Women who access the website, are aged between 38-45 years and are considering screening mammograms will be randomized to either the Decision Aid (a booklet providing information and exercises to help them to make a decision about whether to having screening mammograms) group or the Control Group. The Decision Aid group will first read the decision aid, and then will be asked some demographic and knowledge questions. The control group will be asked the demographic and knowledge questions only. The control group will have access to the Decision Aid after they have completed the questions

NCT ID: NCT00138827 Completed - Clinical trials for Head and Neck Neoplasms

Mouth Care Regimes During Radiotherapy

Start date: November 1999
Phase: Phase 4
Study type: Interventional

The purpose of this study is to assess whether Biotene oral care products have a benefit in the treatment of xerostomia and mucositis when compared with conventional bicarbonate mouth care regimes.

NCT ID: NCT00138788 Completed - Neoplasm Metastasis Clinical Trials

Brain Metastases Study: Radiotherapy Fractionation Schemes in the Treatment of Brain Metastases

Start date: February 1996
Phase: Phase 3
Study type: Interventional

This is a comparison of radiotherapy fractionation schemes for brain metastasis.

NCT ID: NCT00138632 Completed - Clinical trials for Wet Age-Related Macular Degeneration

Safety and Efficacy of Oral PTK787 in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AMD)

ADVANCE
Start date: September 2005
Phase: Phase 1/Phase 2
Study type: Interventional

This study evaluates the tolerability and safety of 3 months treatment with PTK787 tablets given daily. It also explores the efficacy of the compound in patients with wet age-related macular edema. In Cohort 1 verteporfin/PDT is the active control. The protocol was amended to reflect the current standard of care for AMD. As a result, ranibizumab is the active control for Cohort 2.

NCT ID: NCT00137995 Completed - Clinical trials for Lymphoma, Large-Cell, Diffuse

R-ICE Versus R-DHAP in Patients Aged 18-65 With Relapse Diffuse Large B-cell Lymphoma

Start date: June 2003
Phase: Phase 3
Study type: Interventional

The primary objective of this study is to evaluate the efficacy and safety of induction therapy R-ICE in comparison to R-DHAP after 3 cycles adjusted to successful mobilization of stem cells in patients with previously treated diffuse large B-cell lymphoma CD20. The goal is to detect a difference in mobilization adjusted response rate of 15% between R-ICE and R-DHAP. The other objective is to evaluate the efficacy and safety of MabThera maintenance therapy after transplantation as measured by the event free survival. The goal is to obtain a 15% increase of event free survival at 2 years.

NCT ID: NCT00137189 Completed - Mental Disorders Clinical Trials

Resource-oriented Music Therapy for Psychiatric Patients With Low Therapy Motivation

Start date: April 2005
Phase: N/A
Study type: Interventional

The aim of this study is to examine whether resource-oriented music therapy helps psychiatric patients with low therapy motivation to improve negative symptoms and other health-related outcomes.

NCT ID: NCT00136331 Completed - Influenza Clinical Trials

Study of a Pandemic Influenza Vaccine

Start date: October 2005
Phase: Phase 1
Study type: Interventional

The World Health Organisation has warned that an influenza pandemic is inevitable. The avian influenza H5N1 virus strain is the leading candidate to cause the next avian influenza pandemic. This study will test the safety and immunogenicity of a H5N1 pandemic influenza vaccine in healthy adults.

NCT ID: NCT00135876 Completed - Clinical trials for Venous Thromboembolism

Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients

Start date: October 2002
Phase: Phase 3
Study type: Interventional

In patients with malignant glioma, to determine the efficacy of prophylaxis with LMWH (dalteparin) compared to placebo, both commenced beyond the immediate postoperative period, for the prevention of VTE.

NCT ID: NCT00134719 Completed - Clinical trials for Haemophilus Influenzae Type b

Hib-MenCY-TT Vaccine Study Compared to Licensed Hib and Meningococcal Serogroup C Conjugate Vaccines

Start date: April 11, 2005
Phase: Phase 2
Study type: Interventional

This study is evaluating the safety and immunogenicity of Hib-MenCY-TT vaccine compared to control groups receiving licensed Hib or MenC conjugate vaccines, each administered at 2, 4, 6, and 12 to 15 months of age. Co-administration with live, attenuated measles, mumps, and rubella combination vaccine; and with live, attenuated varicella vaccine will be assessed with administration of the booster dose. The Protocol Posting has been updated in order to comply with the FDA Amendment Act, September 2007.

NCT ID: NCT00134693 Completed - Clinical trials for Arthritis, Rheumatoid

A Single Dose Of Compound SB-681323 Compared To Prednisolone On A Protein That Is an Indicator For Rheumatoid Arthritis

Start date: June 21, 2005
Phase: Phase 2
Study type: Interventional

This study is designed to compare a range of doses of SB-681323 with prednisolone, which has known effects on rheumatoid arthritis patients. By comparing the two drugs and their effects on blood proteins that indicate for rheumatoid arthritis, we hope to ascertain information on the most effective dose of SB-681323 to use in future.